Technology NetworksA New CRISPR-Engineered Cancer Model to Test TherapeuticsTechnology NetworksUsing multiplex CRISPR-Cas9 editing of human hematopoietic, or blood-forming, stem cells followed by transplantation in mice, the team designed customized mo… Continue reading
Technology Networks |
CRISPR-Gold Fixes Duchenne Muscular Dystrophy Mutation in Mice
Technology Networks CRISPR–Gold is composed of 15 nanometer gold nanoparticles that are conjugated to thiol-modified oligonucleotides (DNA-Thiol), which are hybridized with single-stranded donor DNA and subsequently complexed with Cas9 and encapsulated by a polymer … |
Sci-News.com |
DNA Shed into Blood by Tumors Can Predict Cancer Patients’ Response to Immunotherapy, Says Study
Sci-News.com Scientists have shown that mutations present in circulating tumor DNA isolated from the blood predicts the likelihood a patient will respond to checkpoint inhibitor immunotherapies, indicating that a simple blood test could inform clinicians on whether … ctDNA mutational load points to checkpoint inhibition outcomesmedwireNews |
WJHL |
Gene therapy helps boys with ‘Lorenzo’s Oil’ disease
WJHL Brian was able to benefit from an experimental treatment while the disease had progressed too far in Brandon to qualify for the gene therapy study. Study results were published Wednesday, Oct. 4 by the New England Journal of Medicine and discussed at … |
|
Arcturus Therapeutics, Inc. to Present at the Chardan Gene Therapy Conference
Markets Insider Chardan’s Inaugural Gene Therapy Conference will feature nearly 30 companies focusing on exciting technologies in gene therapy, including vector-based gene therapy, small RNA and gene editing. The day will consist of fireside chats, individual company … |
|
Biosensors detect harmful bugs in the lungs of cystic fibrosis patients
Imperial College London Professor Paul Freemont, co-founder and co-director of The Centre for Synthetic Biology and Innovation at Imperial, said: “The driving force behind this research is to show that these tools work and could be used to detect particular diagnostic markers … |
PharmaTimes |
Cell and Gene Therapy Catapult in new stem–cell deal
PharmaTimes The Cell and Gene Therapy Catapult (CGT Catapult) will provide its clinical-grade induced Pluripotent Stem Cell (iPSC) line to Seattle based Universal Cells for use in the development of its universal donor cell line. “Induced Pluripotent Stem Cell … CGT Catapult’s iPSC line licensed to Universal Cells for creating universal donor cell lineNews-Medical.net |